English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  51893808    Online Users :  883
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"liu c h"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 136-160 of 1570  (63 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2022-03-09T03:12:26Z R331W missense mutation of oncogene YAP1 is a germline risk allele for lung adenocarcinoma with medical actionability Chen H.-Y.; Yu S.-L.; Ho B.-C.; Su K.-Y.; Hsu Y.-C.; Chang C.-S.; Li Y.-C.; Yang S.-Y.; Hsu P.-Y.; Ho H.; Chang Y.-H.; Chen C.-Y.; Yang H.-I.; Hsu C.-P.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Hsia J.-Y.; Chuang C.-Y.; Yuan S.; Lee M.-H.; Liu C.-H.; Wu G.-I.; Hsiung C.A.; Chen Y.-M.; Wang C.-L.; Huang M.-S.; Yu C.-J.; Chen K.-Y.; Tsai Y.-H.; Su W.-C.; HUEI-WEN CHEN; Chen J.J.W.; Chen C.-J.; Chang G.-C.; Yang P.-C.; Li K.-C.
臺大學術典藏 2022-03-09T03:12:18Z Genome-wide epigenetic landscape of lung adenocarcinoma links HOXB9 DNA methylation to intrinsic EGFR-TKI resistance and heterogeneous responses Su S.-F.; Liu C.-H.; Cheng C.-L.; Ho C.-C.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; HUEI-WEN CHEN; Chang G.-C.; Yu S.-L.; Li K.-C.
臺大學術典藏 2022-03-04T06:55:01Z NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging Su T.-H.; SIH-HAN LIAO; Hong C.-M.; Liu C.-J.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Adhoute X.; Bourlière M.; Kao J.-H.
臺大學術典藏 2022-02-23T02:12:22Z Use of glecaprevir/pibrentasvir in patients with chronic hepatitis c virus infection and severe renal impairment Yap D.Y.H.; Liu K.S.H.; Hsu Y.-C.; Wong G.L.H.; Tsai M.-C.; CHIEN-HUNG CHEN; Hsu C.-S.; Hui Y.T.; Li M.K.K.; Liu C.-H.; Kan Y.-M.; Yu M.-L.; Yuen M.-F.
臺大學術典藏 2022-02-23T02:12:21Z Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan Cheng P.-N.; Mo L.-R.; Chen C.-T.; Chen C.-Y.; Huang C.-F.; Kuo H.-T.; Lo C.-C.; Tseng K.-C.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; CHIEN-HUNG CHEN; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Chang T.S.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Chou K.-H.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; Cheng C.-Y.; Tsai M.-C.; Liu C.-J.; Dai C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L.; Yu M.-L.; TACR investigators
臺大學術典藏 2022-02-22T05:34:11Z Use of glecaprevir/pibrentasvir in patients with chronic hepatitis c virus infection and severe renal impairment Yap D.Y.H.; Liu K.S.H.; Hsu Y.-C.; Wong G.L.H.; Tsai M.-C.; CHIEN-HUNG CHEN; Hsu C.-S.; Hui Y.T.; Li M.K.K.; Liu C.-H.; Kan Y.-M.; Yu M.-L.; Yuen M.-F.
臺大學術典藏 2022-02-22T05:34:10Z Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan Cheng P.-N.; Mo L.-R.; Chen C.-T.; Chen C.-Y.; Huang C.-F.; Kuo H.-T.; Lo C.-C.; Tseng K.-C.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; CHIEN-HUNG CHEN; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Chang T.S.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Chou K.-H.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; Cheng C.-Y.; Tsai M.-C.; Liu C.-J.; Dai C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L.; Yu M.-L.; TACR investigators
臺大學術典藏 2022-02-18T08:26:03Z Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients Lee M.-H.; Huang C.-F.; Lai H.-C.; Lin C.-Y.; Dai C.-Y.; Liu C.-J.; Wang J.-H.; Huang J.-F.; Su W.-P.; Yang H.-C.; Kee K.-M.; Yeh M.-L.; Chuang P.-H.; Hsu S.-J.; Huang C.-I.; Kao J.-T.; CHIEH-CHANG CHEN; Chen S.-H.; Jeng W.-J.; Yang H.-I.; Yuan Y.; Lu S.-N.; Sheen I.-S.; Liu C.-H.; Peng C.-Y.; Kao J.-H.; Yu M.-L.; Chuang W.-L.; Chen C.-J.
臺大學術典藏 2022-02-14T06:28:49Z Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infection Liu C.-H.; Liu C.-J.; Su T.-H.; YU-JEN FANG; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-02-14T06:28:46Z Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis Liu C.-H.; Shih Y.-L.; Yang S.-S.; Lin C.-L.; YU-JEN FANG; Cheng P.-N.; Chen C.-Y.; Peng C.-Y.; Hsieh T.-Y.; Chiu Y.-C.; Su T.-H.; Liu C.-J.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-02-14T06:28:45Z Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment Liu C.-H.; Chen C.-Y.; Su W.-W.; Tseng K.-C.; Lo C.-C.; Liu C.-J.; Chen J.-J.; Peng C.-Y.; Shih Y.-L.; Yang S.-S.; Huang C.-S.; Huang K.-J.; Chang C.-Y.; Tsai M.-C.; Kao W.-Y.; YU-JEN FANG; Chen P.-Y.; Su P.-Y.; Tseng C.-W.; Huang J.-J.; Lee P.-L.; Lai H.-C.; Hsieh T.-Y.; Chang C.-H.; Huang Y.-J.; Lee F.-J.; Chang C.-C.; Kao J.-H.
臺大學術典藏 2022-02-14T06:28:43Z Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis Liu C.-H.; Peng C.-Y.; YU-JEN FANG; Kao W.-Y.; Yang S.-S.; Lin C.-K.; Lai H.-C.; Su W.-P.; Fang S.-U.; Chang C.-C.; Su T.-H.; Liu C.-J.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-02-14T06:28:42Z Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan Liu C.-H.; Chen P.-Y.; Chen J.-J.; Lo C.-C.; Su W.-W.; Tseng K.-C.; Liu C.-J.; Huang C.-S.; Huang K.-J.; Yang S.-S.; Peng C.-Y.; Tsai M.-C.; Kao W.-Y.; Chang C.-Y.; Shih Y.-L.; YU-JEN FANG; Chen C.-Y.; Lee P.-L.; Huang J.-J.; Su P.-Y.; Tseng C.-W.; Hung C.-C.; Chang C.-H.; Huang Y.-J.; Lai H.-C.; Chang C.-C.; Lee F.-J.; Hsieh T.‐Y.; Kao J.-H.
臺大學術典藏 2022-02-14T06:28:42Z Sofosbuvir/velpatasvir plus ribavirin for child-pugh b and child-pugh c hepatitis c virus-related cirrhosis Liu C.-H.; Chen C.-Y.; Su W.-W.; Liu C.-J.; Lo C.-C.; Huang K.-J.; Chen J.-J.; Tseng K.-C.; Chang C.-Y.; Peng C.-Y.; Shih Y.-L.; Huang C.-S.; Kao W.-Y.; Yang S.-S.; Tsai M.-C.; Wu J.-H.; Chen P.-Y.; Su P.-Y.; Hwang J.-J.; YU-JEN FANG; Lee P.-L.; Tseng C.-W.; Lee F.-J.; Lai H.-C.; Hsieh T.-Y.; Chang C.-C.; Chang C.-H.; Huang Y.-J.; Kao J.-H.
臺大學術典藏 2022-02-10T08:29:46Z Practice effects, test–retest reliability, and minimal detectable change of the ruff 2 and 7 selective attention test in patients with schizophrenia Lee P.; Li P.-C.; Liu C.-H.; Lin H.-Y.; CHIEN-YU HUANG; Hsieh C.-L.
臺大學術典藏 2022-02-10T08:29:44Z Practice effects, test–retest reliability, and minimal detectable change of the ruff 2 and 7 selective attention test in patients with schizophrenia Lee P.; Li P.-C.; Liu C.-H.; Lin H.-Y.; Huang C.-Y.; CHING-LIN HSIEH
臺大學術典藏 2022-01-25T05:10:40Z Metabolic profiles in patients with chronic hepatitis C: A case-control study Hsu C.-S.; Liu C.-J.; Liu C.-H.; CHI-LING CHEN; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-25T05:10:40Z High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C Hsu C.-S.; Liu C.-J.; Liu C.-H.; Wang C.-C.; CHI-LING CHEN; Lai M.-Y.; Chen P.-J.; Kao J.-H.; Chen D.-S.
臺大學術典藏 2022-01-25T05:10:38Z High serum adiponectin correlates with advanced liver disease in patients with chronic hepatitis B virus infection Liu C.-J.; Chen P.-J.; Lai M.-Y.; Liu C.-H.; CHI-LING CHEN; Kao J.-H.; Chen D.-S.
臺大學術典藏 2022-01-25T05:10:38Z Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection Hsu C.-S.; Liu C.-H.; Liu C.-J.; Wang C.-C.; CHI-LING CHEN; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-25T05:10:37Z Hepatitis B virus basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis B Liu C.-J.; Jeng Y.-M.; CHI-LING CHEN; Cheng H.-R.; Chen P.-J.; Chen T.-C.; Liu C.-H.; Lai M.-Y.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-25T05:10:37Z Factors affecting early viral load decline of Asian chronic hepatitis C patients receiving pegylated interferon plus ribavirin therapy Hsu C.-S.; Liu C.-H.; Liu C.-J.; CHI-LING CHEN; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-25T05:10:35Z Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection Hsu C.-S.; Liu C.-H.; Liu C.-J.; Hsu S.-J.; CHI-LING CHEN; Hwang J.-J.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-25T05:10:34Z Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B Su T.-H.; Hsu C.-S.; CHI-LING CHEN; Liu C.-H.; Huang Y.-W.; Tseng T.-C.; Liu C.-J.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-25T05:10:33Z HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses Yu M.-L.; Lee C.-M.; Chuang W.-L.; Lu S.-N.; Dai C.-Y.; Huang J.-F.; Lin Z.-Y.; Hu T.-I.; Chen C.-H.; Hung C.-.; Wang J.-H.; CHI-LING CHEN; Kao J.-H.; Lai M.-Y.; Liu C.-H.; Su T.-H.; Wu S.-S.; Liao L.-Y.; Kuo H.-T.; Chao Y.-C.; Tung S.-Y.; Yang S.-S.; Chen P.-J.; Liu C.-J.; Chen D.-S.

Showing items 136-160 of 1570  (63 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page